A1 Refereed original research article in a scientific journal

Novel Hydrazine Molecules as Tools To Understand the Flexibility of Vascular Adhesion Protein-1 Ligand-Binding Site: Toward More Selective Inhibitors




AuthorsNurminen EM, Pihlavisto M, Lazar L, Pentikainen U, Fulop F, Pentikainen OT

PublisherAMER CHEMICAL SOC

Publication year2011

Journal: Journal of Medicinal Chemistry

Journal name in sourceJOURNAL OF MEDICINAL CHEMISTRY

Journal acronymJ MED CHEM

Volume54

Issue7

First page 2143

Last page2154

Number of pages12

ISSN0022-2623

DOIhttps://doi.org/10.1021/jm200059p


Abstract
Vascular adhesion protein-1 (VAP-1) belongs to a family of amine oxidases. It plays a role in leukocyte trafficking and in amine compound metabolism. VAP-1 is linked to various diseases, such as Alzheimer's disease, psoriasis, depression, diabetes, and obesity. Accordingly, selective inhibitors of VAP-1 could potentially be used to treat those diseases. In this study, eight novel VAP-1 hydrazine derivatives were synthesized and their VAP-1 and monoamine oxidase (MAO) inhibition ability was determined in vitro. MD simulations of VAP-1 with these new molecules reveal that the VAP-1 ligand-binding pocket is flexible and capable of fitting substantially larger ligands than was previously believed. The increase in the size of the VAP-1 ligands, together with the methylation of the secondary nitrogen atom of the hydrazine moiety, improves the VAP-1 selectivity over MAO.



Last updated on 2024-26-11 at 15:44